創世紀(300083.SZ):在美國地區尚無直接業務收入
格隆匯7月11日丨創世紀(300083.SZ)在互動平臺表示,公司在美國地區尚無直接業務收入,本次美國加增關稅事件對公司無直接影響;同時,公司的核心技術與零部件採購均不涉及原產地美國商品,美國提高關稅未對公司產品的生產和銷售構成衝擊。公司將密切關注貿易政策、貿易環境的變化與發展,積極靈活調整市場策略和經營管理策略,增強公司抗風險能力。目前公司訂單情況良好,現有產能利用率飽和,具體經營情況請關注公司定期報告。短期,公司的股價受宏觀與行業環境、市場情緒、投資者預期等多種因素影響。公司將繼續聚焦主業做大做強,持續提升公司經營效益,以優良的業績回報投資者。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.